BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16424702)

  • 1. Occult carcinoma of the thyroid presenting with orbital metastasis.
    Mansberg R; Son H; Kean AM
    Clin Nucl Med; 2006 Feb; 31(2):109-11. PubMed ID: 16424702
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine.
    Borsò E; Boni G; Mazzarri S; Cocciaro A; Gambacciani C; Traino AC; Manca G; Grosso M; Scatena C; Ortenzi V; Vannozzi R; Marzola MC; Rubello D; Mariani G
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):111-5. PubMed ID: 25455505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
    Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
    Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
    Salvatori M; Luster M
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
    Burniston MT; Wilson DJ
    J Nucl Med; 2008 Jan; 49(1):166; author reply 166-7. PubMed ID: 18165699
    [No Abstract]   [Full Text] [Related]  

  • 6. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma.
    Andreas J; Brühl K; Eissner D
    Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
    Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
    J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer].
    Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM
    Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of metastases to internal jugular vein and superior vena cava on 131-I scan.
    Agrawal A; Agrawal R; Asopa R
    Clin Nucl Med; 2009 Dec; 34(12):934-5. PubMed ID: 20139840
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thyroid cancer: metabolic treatment and follow-up using thyroglobulin levels and I-131 gammagraphy].
    Lampreave JL; Trampal C; Domínguez P; Bittini A
    Rev Clin Esp; 1998 May; 198(5):307-15. PubMed ID: 9658914
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous metastasis revealing a widely disseminated follicular thyroid carcinoma.
    Boughattas S; Hassine H; Chatti K; Jomaa R; Essabbah H
    Clin Nucl Med; 2002 May; 27(5):379-80. PubMed ID: 11953583
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative scintigraphic visualization of an orbital metastasis before identification of carcinoma in a nonfunctioning thyroid nodule.
    Boughattas S; Khochtali H; Arifa N; Degdegui M; Hassine H; Bakir A; Essabbah H
    Clin Nucl Med; 2004 Apr; 29(4):249-50. PubMed ID: 15096972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hiatus hernia: a potential cause of false-positive iodine-131 scan in thyroid carcinoma.
    Ho Y; Hicks R
    Clin Nucl Med; 1998 Sep; 23(9):621-2. PubMed ID: 9735991
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
    J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive I-131 images mimicking thyroid cancer metastasis. The nose ring sign.
    Dick C; Mudun A; Alazraki NP
    Clin Nucl Med; 1995 Oct; 20(10):876-7. PubMed ID: 8616990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.